Admission Date:  [**2155-7-19**]              Discharge Date:   [**2155-7-22**]  Date of Birth:  [**2090-10-10**]             Sex:   F  Service: MEDICINE  Allergies: fentanyl / Cipro / Pemetrexed  Attending:[**First Name3 (LF) 87302**] Chief Complaint:  cellulitis   Major Surgical or Invasive Procedure: none  History of Present Illness: 64 y.o female with primary peritoneal carcinoma last round of Topotecan ending [**2155-7-1**], lung metastases, and recent right humerus fracture with 2 recent admissions for cellulitis/dehydration ([**Date range (1) 62150**]/[**2154**]) presenting with hypotension, decreased p.o intake and mild dyspnea.
Ms. [**Known lastname **] has had 2 recent admissions (discharged on [**2155-7-9**] and [**2155-7-17**] from [**Hospital1 18**]) for cellulitis around her peritoneal catheter site.
During the first admission she was started on vancomycin and discarged on this medication; however, when she was admitted on [**2155-7-14**], her vanc level was 51.6 and this antibiotic was discontinued.
Patient was given Zosyn and Vancomycin, rectal tylenol.
She was initially started on azithromycin for atypical lung pathogens (source of fever had not been entirely elucidated) but this was stopped.
ROS: Positive for malaise, fatigue, constipation.
Denies chest pain, chest pressure, palpitations, or weakness.
Past Medical History: - Primary Peritoneal Carcinoma -- papillary serous adenocarcinoma - ([**5-/2152**]) diagnosed stage 4 with malignant ascites, pleural effusions, and axillary nodes - lung metastases -- most recently treated with Topotecan - Right Humerus Fracture -- recent -Chronic Kidney Disease -- Stage 3 -Hypertension -Hypothyroidism -Asthma -Mitral Valve Prolapse -Dupuytren's Disease - Anemia -HSV-1 Infection .
[**2152-6-15**] Carboplatin/taxol x 4 [**2152-8-29**] Expl lap, omentectomy, TAH/BSO, appendectomy with radical debulking, Dr. [**Last Name (STitle) 102265**], with all visible disease removed or separated from adjacent organs.
Tumor involved left ovary and tube as serosal and surface adhesions, with no parenchymal involvement.
[**2153-6-20**] Avastin added.
[**2153-12-11**] Avastin as monotherapy for maintenance - last dose [**2154-4-3**] [**2154-3-29**] CT Torso: (CA 125 rising) Mild thickening and narrowing of the distal ileum which is likely due to contraction.
Abdomen/pelvis: Extensive peritoneal, mesenteric, and omental metastases.
[**2154-11-4**] Start Carboplatin (lifetime dose #14) [**2154-11-27**] [**Doctor Last Name **] dose #2 [**2154-12-18**] [**Doctor Last Name **] dose #3 [**2155-1-19**] [**Doctor Last Name **] # 4 in FL [**2155-2-17**] Gemzar in FL, last dose [**2155-2-27**] (reduced by 50%) - No response, marked myelosuppression.
[**2155-3-21**] Altima dose #1 [**3-28**] Seen for dehydration and drug rash, hydrated, given IV steroids and benadryl [**Date range (1) 21715**] Admitted [**Hospital1 18**] for progressive allergic reaction including essentially erythroderm, fever and rigors, no mucous membrane involvement.
Cultures negative [**2155-4-11**] Cycle #1 Cytoxan and Doxil [**2155-4-14**] underwent paracentesis at the [**Hospital1 18**] with removal of 5.3 liters of ascites [**2155-4-23**] Seen at [**Hospital1 18**] for blood transfusion and orthostatic.
Had been started on Cipro [**4-22**] for UTI and had vomiting and diarrhea.
[**2155-5-1**] Cycle #2 Cytoxan and Doxil with neulasta [**2155-5-9**] Transfusion 1 unit pRBC at [**Hospital1 18**] [**2155-5-13**] Paracentesis at [**Hospital1 18**], 5 liters.
[**Date range (3) 102269**] for pain control following a fall resulting in a comminuted fracture of the right proximal humerus.
She was evaluated by orthopedics and managed conservatively with non-surgical interventions.
She also had a peritoneal drain placed by IR prior to discharge [**Date range (3) 102270**] admitted for port-a-cath placement, and received a chemotherapy [**6-4**] with Topotecan.
[**2155-6-4**] Given #1 Topotecan at dose reduction to 2mg/m2 [**2155-6-12**] Pancytopenic, chemo held [**2155-6-20**] Topotecan with further dose reduction, Neupogen day 2,3,4 [**2155-6-27**] Topotecan [**2155-7-14**]- CT abdomen and pelvis w/o contrast New extra-abdominal metastases noted along the partly visualized right lower chest wall [**2155-7-17**]- RUQ u/s with multiple liver metastasis no portal vein thrombosis   Social History: Married, husband is very supportive.
Erythema around LLQ catheter site with associated rubor outlined by pen approx 7cm-8cm.
Interval development of upper lobe predominant multifocal patchy ground-glass and heterogeneous airspace opacities with a central/paramediastinal distribution.
[**2155-7-22**] 05:24AM BLOOD Glucose-62* UreaN-24* Creat-2.1* Na-127* K-3.4 Cl-97 HCO3-19* AnGap-14 [**2155-7-22**] 05:24AM BLOOD ALT-18 AST-36 LD(LDH)-684* AlkPhos-236* TotBili-0.4 [**2155-7-22**] 05:24AM BLOOD Calcium-7.4* Phos-3.2 Mg-2.1  Brief Hospital Course: 64 y.o female with primary peritoneal carcinoma last round of Topotecan ending [**2155-7-1**], lung metastases, and recent right humerus fracture with 2 recent admissions for cellulitis/dehydration ([**Date range (1) 62150**]/[**2154**]) presenting with hypotension and mild dyspnea.
Diuresis was attempted without success (see below) due to acute kidney failure.
Given progressive cancer on imaging and poor overall prognosis, goals of care were discussed with the family and the decision was made to pursue comfort measures only.
Palliative care was involved and patient was given IV dilaudid and ativan and given hyoscyamine to manage secretions and zofran for nausea.
#Hypotension- Likely sepsis with catheter associated cellulitis as source with element of volume depletion.
Given recent admission covered with Vancomycin/Zosyn/azithro empirically.
Got 3L NS in ED.
Weaned down from 6L to 2L NC overnight.
TTE showed normal EF, trivial pericardial effusion, mitral and tricuspid regurgitation and mild pulmonary hypertension.
She was given albumin in an attempt to improve intravascular volume, and later given albumin and Lasix in attempt for diuresis, but these efforts were unsuccessful.
Patient and family decided against pursuing dialysis given goals of care.
#Primary Metastatic Peritoneal Carcinoma- s/p Topotecan late [**2155-6-8**].
Given IVF as above and zofran for nausea.
Medications on Admission: Medications HOME:Per DC summary [**2155-7-17**] Discharge Medications: 1.
CeftriaXONE 1 gm IV Q24H RX *ceftriaxone 1 gram 1 gram IV q24 hours Disp #*3 Gram Refills:*0 2.
IV fluids Please adminster 1 L NS at 100cc/hr once a week 4.
Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing 5.
Docusate Sodium 100 mg PO QID:PRN constipation 6.
FoLIC Acid 1 mg PO DAILY 7.
Gabapentin 300 mg PO BID 8.
HYDROmorphone (Dilaudid) 2-4 mg PO Q4H:PRN pain 9.
Levothyroxine Sodium 88 mcg PO DAILY 10.
Lorazepam 0.5 mg PO Q4H:PRN nausea 11.
Lorazepam 1-2 mg PO HS:PRN insomnia 12.
Prochlorperazine 10 mg PO Q6H:PRN nausea 13.
Sarna Lotion 1 Appl TP QID:PRN itching 14.
Senna 1 TAB PO BID 15.
Magnesium Oxide 400 mg PO DAILY:PRN constipation 16.
Omeprazole 40 mg PO DAILY:PRN heartburn/during chemo 17.
Clobetasol Propionate 0.05% Cream 1 Appl TP [**Hospital1 **]   Discharge Medications: N/A  Discharge Disposition: Expired  Discharge Diagnosis: Primary peritoneal carcinomatosis Sepsis Acute renal failure  Discharge Condition: Deceased  Discharge Instructions: N/A  Followup Instructions: N/A   Completed by:[**2155-8-5**
